2016 Showcase Presenters | Boulder Peptide Symposium

September 15-18, 2025

LIVE, In Person at the St. Julien Hotel in Boulder, Colorado
The only conference focused solely on the pharmaceutical development of peptide therapeutics.
MENU

2016 Showcase Presenters

2016 Showcase Presenters
BPS News, News February 17, 2016

Eric Fang
Snapdragon Chemistry, a Cambrex Company

Liquid-phase peptide fragment manufacturing technologies and workflows using batch and flow chemistry

Corey Adams
NoNO Inc.

Clinical Development of a PSD-95 Inhibitor for Acute Ischemic Stroke

Taeju Park
Children's Mercy Kansas City

Rational design of peptides to inhibit protein-protein interactions and block tumor cell migration

Taeju Park
Children's Mercy Kansas City

Rational design of peptides to inhibit protein-protein interactions and block tumor cell migration

Stephanie Seminara
Mass General Brigham

A Kiss to Remember

Alessia Santoprete
IRBM SPA

R2R01: a potent Long-Acting RXFP1 peptide agonist in Phase 2 Development for Cardiovascular and Renal Disorders

Shubhangini Verma
Indian Institute of Technology Guwahati

Injectable and biocompatible hydrogel from amyloidogenic peptide stretch of human tau306–311

Marvin Albers
VU Amsterdam

grabRNA: Smart RNA delivery enables novel therapeutic strategies

Peptide Showcase
Benyi Li
KANSAS UNIV MEDICAL CENTER

An AR protein degrader for prostate cancer therapy

John McGee
Parabilis Medicines

Discovery of FOG-001, a Direct Inhibitor of the β-Catenin/TCF Interaction

Peptide Showcase
Justin Northrup
ThirdLaw Molecular

Macromolecules to Discover Low Nanomolar Binders for TNF-alpha

" ]

Anthony Silvestri
Unnatural Products

Tales of macrocycle medchem: leveraging peptide discovery and optimization technologies

Andre Watson
Ligandal

Peptides for Use in Targeting Payloads

Drug Delivery
Christian Becker
University of Vienna

Targeted innate immune stimulators as therapeutics

Drug Delivery
Katerina Leftheris
Stony Brook University/Vilya, Inc.

Targeting Peptides and Macrocycles as Drugs: Novel approaches on the Horizon

Connor Thomson
Sinopep

Real-world, achievable strategies to improve sustainability in GLP-1 peptide manufacturing (and why it might not matter)

Panel Discussion: Peptides as Radiopharmaceuticals
Murray Wan
Mariana Oncology

Peptide Radiopharmaceutical Panel

Robin Polt
The University of Arizona

Brain Penetrant Glycopeptide Drugs from Endogenous Neuropeptides

Peptide Showcase
Nicolas Gilles
CEA

A snake peptide toxin for treatment of kidney diseases. From bench to bedside

Chemistry of Complex Peptides
Akshay Shah
Pinnacle Medicines

Enablement of Late-Stage Functionalization and High-Throughput Parallel Chemistry for Efficient Peptide Optimization

Chemistry of Complex Peptides
Cesar de la Fuente
University of Pennsylvania

AI for Antibiotic Discovery

Peptides in the Clinic
Kathy Miller
Indiana University

Peptide vaccines for prevention and treatment of cancer

Drug Delivery
Guizhi Zhu
University of Michigan

Engineer and deliver peptide-based proteolysis-targeting vaccines (PROTAX) for cancer immunotherapy

Ross Wang
Temple University

Fluorine-Displacement Reaction (FDR)-mediated Peptide Stapling to Interrogate Protein-Protein Interactions

Jamie Shah
Chem-Impex

Reagents, Relationships, and Resilience: What Family Business Can Teach Us About Peptide Innovation

Chemistry of Complex Peptides
Soren Ostergaard
Novo Nordisk A/S

Half-life extension of peptides using fatty acid derivatization; past, present and future opportunities

Daniela Kalafatovic
University of Rijeka

Using Generative AI to Fast Track Peptide Discovery

AI/Machine Learning with Peptides Workshop
Goran Mausa
University of Rijeka, Faculty of Engineering

AI/Machine Learning Workshop

Drug Delivery
Zhigao Niu
Novo Nordisk

Efforts to improve the SNAC-based formulations for oral peptide delivery

AI/Machine Learning with Peptides Workshop
Nicolai Ree
Gubra

AI/Machine Learning Worshop

Peptide Showcase
Stephane Roche
AdaptBio Therapeutics

ADAPT: An Emerging Platform of Antibody CDR-H3-based Scaffolds for the Discovery of Novel Classes of Protein-Protein Interaction Inhibitors

Lauren Cline
BPS

This is just a test

Chemistry of Complex Peptides
Tom Tucker
Merck and Co., Inc.

Discovery of the Highly Potent and Orally Bioavailable Cyclic Peptide PCSK9 Inhibitor MK-0616

Chemistry of Complex Peptides
Christian Gruber
Medical University of Vienna

Peptide-based approaches to GPCR drug discovery: novel κ-opioid receptor ligands for applications in inflammatory pain

Peptides in the Clinic
Jeff Alberts
Eli Lilly and Company

The Journey of Bioanalytical Support for Peptides from Target of Interest to Post Market

Mandë Holford
Hunter College - CUNY

Killer Snails: Agents of Change and Innovation

Walden Bjørn-Yoshimoto
University of Copenhagen

Somatostatin receptor 4 activating conopeptides inspiring a new class of pain therapeutics

s2Member®
loading...